BioCorRx (BICX) Shares Outstanding (Weighted Average) (2010 - 2026)

BioCorRx has disclosed Shares Outstanding (Weighted Average) across 17 years of filings, most recently posting $28.9 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $28.9 million, up 91.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.9 million (up 91.5% YoY), and the FY2025 annual result was $24.5 million, up 134.03% from the prior year.
• Shares Outstanding (Weighted Average) came in at $28.9 million for Q1 2026 at BioCorRx, up from $24.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $28.9 million in Q1 2026 to a low of $6.9 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $8.8 million (2024), against an average of $12.1 million.
• Across the five-year window, Shares Outstanding (Weighted Average) grew 5.46% in 2022 and jumped 134.03% in 2025, its largest moves.
• BioCorRx's Shares Outstanding (Weighted Average) stood at $7.2 million in 2022, then advanced by 15.92% to $8.3 million in 2023, then increased by 25.41% to $10.5 million in 2024, then jumped by 134.03% to $24.5 million in 2025, then climbed by 18.04% to $28.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $28.9 million (Q1 2026), $24.5 million (Q4 2025), and $20.2 million (Q3 2025), per Business Quant data.